| Document Date: 2015-04-27 01:38:18
Open Document File Size: 410,91 KBShare Result on Facebook
City Redwood City / Durham / / Company QIAGEN / IPA / / Country United States / / Event Diplomatic Relations / / IndustryTerm given network / metastasis network / web-based applications / interactive and visual tools / molecular network / web platform / plausible directional networks / driven-mechanistic network / biological networks / cancer therapies / gene-gene and gene-phenotype networks / upstream tools / visual tools / molecular and chemical interactions / functional and predictive algorithms / sub-networks / evidence-based algorithm / healthcare / transcription regulators network / mechanistic network / chemical modifications / / MedicalCondition invasive ductal carcinomas / cancers / tumor / malignant tumors / luminal tumors / cancer / tumors / disease / metastasis / invasive and metastatic cancers / luminal breast tumors / given tumor / CD44positive breast tumor / breast tumors / epithelial tumor / diseases / studied tumor / tumor metastasis / aggressive tumors / prostate cancer / breast cancer / / MedicalTreatment endocrine therapy / cancer therapies / / Person Genome Scientist / Jean-Noel Billaud / / Position driver / Fisher / representative / Scientist / / Technology Genomics / Assay Technologies / evidence-based algorithm / gene expression / functional and predictive algorithms / stem cells / human genome / apoptosis / BSIFT algorithm / / URL www.qiagen.com / /
SocialTag |
ApplicationNote Understanding Breast Cancer Subtypes by Jointly Interpreting Tumor Genomes and Transcriptomes Jean-Noel Billaud, Principal Scientist, and Nathan Pearson, Principal Genome Scientist QIAGEN Silicon Valley,